Telemedicine-supported assisted home hemodialysis in elderly and multimorbid patients: a real-world cohort study in a public healthcare system.

IF 1.9 4区 医学 Q3 UROLOGY & NEPHROLOGY
Anna Zito, Paolo Ria, Maria Luisa Lefons, Vilma Martella, Silvia Matino, Giulia Fontò, Silvia Barbarini, Tiziana Rollo, Marcello Napoli, Antonio De Pascalis
{"title":"Telemedicine-supported assisted home hemodialysis in elderly and multimorbid patients: a real-world cohort study in a public healthcare system.","authors":"Anna Zito, Paolo Ria, Maria Luisa Lefons, Vilma Martella, Silvia Matino, Giulia Fontò, Silvia Barbarini, Tiziana Rollo, Marcello Napoli, Antonio De Pascalis","doi":"10.1007/s11255-026-05115-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The aging of the hemodialysis (HD) population and the growing burden of multimorbidity increasingly challenge the sustainability and equity of conventional in-center dialysis within publicly funded healthcare systems. Although home hemodialysis (HHD) may offer clinical and organizational advantages, its implementation remains limited among elderly and functionally dependent patients. We evaluated the real-world feasibility, retention, and system-level impact of a telemedicine-supported assisted-HHD (A-HHD) program aimed at broadening access to complex individuals. We performed a retrospective, descriptive observational cohort study including all patients enrolled in an A-HHD program within a public healthcare authority in Southern Italy from June 2018 to June 2025. In September 2023, a structured telemedicine platform enabling real-time remote monitoring and audiovisual supervision was integrated into routine care. We assessed epidemiological trends, patient complexity, vascular access patterns, dialysis prescription and delivered dose, treatment retention, causes of discontinuation, and transportation-related economic outcomes.</p><p><strong>Results: </strong>A total of 146 patients (mean age 79 ± 7 years) with substantial cardiovascular, metabolic, and respiratory comorbidity were treated. Central venous catheters were used in 64% of cases. Following early program expansion, annual incidence stabilized at approximately 20-25 patients, while prevalence steadily increased, exceeding 20 active patients per month. More than half of patients remained on therapy beyond 6 months. Despite shorter individual sessions, increased treatment frequency achieved a weekly standard Kt/V comparable to conventional in-center HD. Treatment discontinuation was predominantly related to mortality or clinical indications rather than program failure.</p><p><strong>Conclusion: </strong>Telemedicine-supported A-HHD represents a feasible and organizationally sustainable model capable of expanding equitable access to home-based dialysis while supporting organizational sustainability in public healthcare systems.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2026-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-026-05115-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The aging of the hemodialysis (HD) population and the growing burden of multimorbidity increasingly challenge the sustainability and equity of conventional in-center dialysis within publicly funded healthcare systems. Although home hemodialysis (HHD) may offer clinical and organizational advantages, its implementation remains limited among elderly and functionally dependent patients. We evaluated the real-world feasibility, retention, and system-level impact of a telemedicine-supported assisted-HHD (A-HHD) program aimed at broadening access to complex individuals. We performed a retrospective, descriptive observational cohort study including all patients enrolled in an A-HHD program within a public healthcare authority in Southern Italy from June 2018 to June 2025. In September 2023, a structured telemedicine platform enabling real-time remote monitoring and audiovisual supervision was integrated into routine care. We assessed epidemiological trends, patient complexity, vascular access patterns, dialysis prescription and delivered dose, treatment retention, causes of discontinuation, and transportation-related economic outcomes.

Results: A total of 146 patients (mean age 79 ± 7 years) with substantial cardiovascular, metabolic, and respiratory comorbidity were treated. Central venous catheters were used in 64% of cases. Following early program expansion, annual incidence stabilized at approximately 20-25 patients, while prevalence steadily increased, exceeding 20 active patients per month. More than half of patients remained on therapy beyond 6 months. Despite shorter individual sessions, increased treatment frequency achieved a weekly standard Kt/V comparable to conventional in-center HD. Treatment discontinuation was predominantly related to mortality or clinical indications rather than program failure.

Conclusion: Telemedicine-supported A-HHD represents a feasible and organizationally sustainable model capable of expanding equitable access to home-based dialysis while supporting organizational sustainability in public healthcare systems.

远程医疗支持的辅助家庭血液透析在老年人和多病患者:一个现实世界的队列研究在公共卫生系统。
目的:血液透析(HD)人群的老龄化和日益增长的多重疾病负担日益挑战公共资助医疗系统中传统中心透析的可持续性和公平性。尽管家庭血液透析(HHD)可能提供临床和组织优势,但其在老年人和功能依赖患者中的实施仍然有限。我们评估了远程医疗支持的辅助hhd (a - hhd)项目的现实可行性、保留率和系统级影响,该项目旨在扩大对复杂个体的访问。我们进行了一项回顾性、描述性观察性队列研究,包括2018年6月至2025年6月在意大利南部一家公共卫生机构参加a - hhd项目的所有患者。2023年9月,将实现实时远程监控和视听监督的结构化远程医疗平台整合到日常护理中。我们评估了流行病学趋势、患者复杂性、血管通路模式、透析处方和输送剂量、治疗保留、停药原因和运输相关的经济结果。结果:共治疗了146例(平均年龄79±7岁)伴有心血管、代谢和呼吸合并症的患者。中心静脉置管占64%。在早期项目扩大后,年发病率稳定在约20-25例,而患病率稳步上升,每月超过20例活跃患者。超过一半的患者继续接受治疗超过6个月。尽管单个疗程较短,但增加的治疗频率达到了每周标准Kt/V,与传统的中心HD相当。中断治疗主要与死亡率或临床指征有关,而与治疗方案失败无关。结论:远程医疗支持的a - hhd代表了一种可行且组织可持续的模式,能够扩大家庭透析的公平获取,同时支持公共卫生系统的组织可持续性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Urology and Nephrology
International Urology and Nephrology 医学-泌尿学与肾脏学
CiteScore
3.40
自引率
5.00%
发文量
329
审稿时长
1.7 months
期刊介绍: International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书